Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Avanafil (Cas 330784-47-9)
Revenue, means the sales value of Avanafil (Cas 330784-47-9)
This report studies Avanafil (Cas 330784-47-9) in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
VIVUS
Menarini Group
Auxilium Pharmaceuticals, Inc
Sanofi
Endo International
JW Pharmaceutical
...
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
By Dosage
50mg
100mg
200mg
By Purity
?99%
Other
Split by Application, this report focuses on consumption, market share and growth rate of Avanafil (Cas 330784-47-9) in each application, can be divided into
Pharmaceutical
Other
China Avanafil (Cas 330784-47-9) Market Research Report 2017
1 Avanafil (Cas 330784-47-9) Market Overview
1.1 Product Overview and Scope of Avanafil (Cas 330784-47-9)
1.2 Avanafil (Cas 330784-47-9) Segment by Type
1.2.1 China Production Market Share of Avanafil (Cas 330784-47-9) Type in 2015
1.2.2 By Dosage
1.2.3 50mg
1.2.4 100mg
1.2.5 200mg
1.2.6 By Purity
1.2.7 ?99%
1.2.8 Other
1.3 Applications of Avanafil (Cas 330784-47-9)
1.3.1 Avanafil (Cas 330784-47-9) Consumption Market Share by Application in 2015
1.3.2 Pharmaceutical
1.3.3 Other
1.4 China Market Size (Value) of Avanafil (Cas 330784-47-9) (2011-2021)
1.5 China Avanafil (Cas 330784-47-9) Status and Outlook
1.6 Government Policies
2 China Avanafil (Cas 330784-47-9) Market Competition by Manufacturers
2.1 China Avanafil (Cas 330784-47-9) Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Avanafil (Cas 330784-47-9) Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Avanafil (Cas 330784-47-9) Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Avanafil (Cas 330784-47-9) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Avanafil (Cas 330784-47-9) Market Competitive Situation and Trends
2.5.1 Avanafil (Cas 330784-47-9) Market Concentration Rate
2.5.2 Avanafil (Cas 330784-47-9) Market Share of Top 3 and Top 5 Manufacturers
3 China Avanafil (Cas 330784-47-9) Manufacturers ProfilesAnalysis
3.1 VIVUS
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.1.2.1 By Dosage
3.1.2.2 50mg
3.1.3 VIVUS Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main BusinessBusiness Overview
3.2 Menarini Group
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.2.2.1 By Dosage
3.2.2.2 50mg
3.2.3 Menarini Group 101 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main BusinessBusiness Overview
3.3 Auxilium Pharmaceuticals, Inc
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.3.2.1 By Dosage
3.3.2.2 50mg
3.3.3 Auxilium Pharmaceuticals, Inc 109 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main BusinessBusiness Overview
3.4 Sanofi
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.4.2.1 By Dosage
3.4.2.2 50mg
3.4.3 Sanofi Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main BusinessBusiness Overview
3.5 Endo International
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.5.2.1 By Dosage
3.5.2.2 50mg
3.5.3 Endo International Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main BusinessBusiness Overview
3.6 JW Pharmaceutical
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
3.6.2.1 By Dosage
3.6.2.2 50mg
3.6.3 JW Pharmaceutical Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main BusinessBusiness Overview
...
4 China Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Avanafil (Cas 330784-47-9) Capacity, Production and Growth (2011-2016)
4.2 China Avanafil (Cas 330784-47-9) Revenue and Growth (2011-2016)
4.3 China Avanafil (Cas 330784-47-9) Production, Consumption, Export and Import (2011-2016)
5 China Avanafil (Cas 330784-47-9) Production, Revenue (Value), Price Trend by Type
5.1 China Avanafil (Cas 330784-47-9) Production and Market Share by Type (2011-2016)
5.2 China Avanafil (Cas 330784-47-9) Revenue and Market Share by Type (2011-2016)
5.3 China Avanafil (Cas 330784-47-9) Price by Type (2011-2016)
5.4 China Avanafil (Cas 330784-47-9) Production Growth by Type (2011-2016)
6 China Avanafil (Cas 330784-47-9) Market Analysis by Application
6.1 China Avanafil (Cas 330784-47-9) Consumption and Market Share by Application (2011-2016)
6.2 China Avanafil (Cas 330784-47-9) Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging MarketsCountries
7 ChinaAvanafil (Cas 330784-47-9) Market Analysis by Regions (Provinces)
7.1 China Avanafil (Cas 330784-47-9) Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Avanafil (Cas 330784-47-9) Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Avanafil (Cas 330784-47-9) Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Avanafil (Cas 330784-47-9) Sales Price by Regions (Provinces)(2011-2016)
7.2 China Avanafil (Cas 330784-47-9) Consumption by Regions (Provinces)(2011-2016)
7.3 China Avanafil (Cas 330784-47-9) Production, Consumption, Export and Import (2011-2016)
8 Avanafil (Cas 330784-47-9) Manufacturing Cost Analysis
8.1 Avanafil (Cas 330784-47-9) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Avanafil (Cas 330784-47-9) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, DistributorsTraders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 DistributorsTraders List
11 Market Effect Factors Analysis
11.1 Technology ProgressRisk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer NeedsCustomer Preference Change
11.3 EconomicPolitical Environmental Change
12 China Avanafil (Cas 330784-47-9) Market Forecast (2016-2021)
12.1 China Avanafil (Cas 330784-47-9) Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Avanafil (Cas 330784-47-9) Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Avanafil (Cas 330784-47-9) Production Forecast by Type (2016-2021)
12.4 China Avanafil (Cas 330784-47-9) Consumption Forecast by Application (2016-2021)
12.5 China Avanafil (Cas 330784-47-9) Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Avanafil (Cas 330784-47-9) Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Avanafil (Cas 330784-47-9) Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Avanafil (Cas 330784-47-9) Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Avanafil (Cas 330784-47-9) Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Avanafil (Cas 330784-47-9)
Figure China Production Market Share of Avanafil (Cas 330784-47-9) by Type in 2015
Figure Product Picture of By Dosage
Table Major Manufacturers of By Dosage
Figure Product Picture of 50mg
Table Major Manufacturers of 50mg
Figure Product Picture of 100mg
Table Major Manufacturers of 100mg
Figure Product Picture of 200mg
Table Major Manufacturers of 200mg
Figure Product Picture of By Purity
Table Major Manufacturers of By Purity
Figure Product Picture of ?99%
Table Major Manufacturers of ?99%
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Avanafil (Cas 330784-47-9) Consumption Market Share by Application in 2015
Figure Pharmaceutical Examples
Figure Other Examples
Figure China Avanafil (Cas 330784-47-9) Revenue (Million USD) and Growth Rate (2011-2021)
Table China Avanafil (Cas 330784-47-9) Capacity of Key Manufacturers (2015 and 2016)
Table China Avanafil (Cas 330784-47-9) Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Avanafil (Cas 330784-47-9) Capacity of Key Manufacturers in 2015
Figure China Avanafil (Cas 330784-47-9) Capacity of Key Manufacturers in 2016
Table China Avanafil (Cas 330784-47-9) Production of Key Manufacturers (2015 and 2016)
Table China Avanafil (Cas 330784-47-9) Production Share by Manufacturers (2015 and 2016)
Figure 2015 Avanafil (Cas 330784-47-9) Production Share by Manufacturers
Figure 2016 Avanafil (Cas 330784-47-9) Production Share by Manufacturers
Table China Avanafil (Cas 330784-47-9) Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table 2016 China Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table China Market Avanafil (Cas 330784-47-9) Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Avanafil (Cas 330784-47-9) Average Price of Key Manufacturers in 2015
Table Manufacturers Avanafil (Cas 330784-47-9) Manufacturing Base Distribution and Sales Area
Table Manufacturers Avanafil (Cas 330784-47-9) Product Type
Figure Avanafil (Cas 330784-47-9) Market Share of Top 3 Manufacturers
Figure Avanafil (Cas 330784-47-9) Market Share of Top 5 Manufacturers
Table VIVUS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table VIVUS Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure VIVUS Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Table Menarini Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Menarini Group Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Menarini Group Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Table Auxilium Pharmaceuticals, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Table Endo International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo International Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Endo International Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Table JW Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table JW Pharmaceutical Avanafil (Cas 330784-47-9) Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure JW Pharmaceutical Avanafil (Cas 330784-47-9) Market Share (2011-2016)
Figure China Avanafil (Cas 330784-47-9) Capacity, Production and Growth (2011-2016)
Figure China Avanafil (Cas 330784-47-9) Revenue (Million USD) and Growth (2011-2016)
Table China Avanafil (Cas 330784-47-9) Production, Consumption, Export and Import (2011-2016)
Table China Avanafil (Cas 330784-47-9) Production by Type (2011-2016)
Table China Avanafil (Cas 330784-47-9) Production Share by Type (2011-2016)
Figure Production Market Share of Avanafil (Cas 330784-47-9) by Type (2011-2016)
Figure 2015 Production Market Share of Avanafil (Cas 330784-47-9) by Type
Table China Avanafil (Cas 330784-47-9) Revenue by Type (2011-2016)
Table China Avanafil (Cas 330784-47-9) Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Avanafil (Cas 330784-47-9) by Type (2011-2016)
Figure 2015 Revenue Market Share of Avanafil (Cas 330784-47-9) by Type
Table China Avanafil (Cas 330784-47-9) Price by Type (2011-2016)
Figure China Avanafil (Cas 330784-47-9) Production Growth by Type (2011-2016)
Table China Avanafil (Cas 330784-47-9) Consumption by Application (2011-2016)
Table China Avanafil (Cas 330784-47-9) Consumption Market Share by Application (2011-2016)
Figure China Avanafil (Cas 330784-47-9) Consumption Market Share by Application in 2015
Table China Avanafil (Cas 330784-47-9) Consumption Growth Rate by Application (2011-2016)
Figure China Avanafil (Cas 330784-47-9) Consumption Growth Rate by Application (2011-2016)
Table China Avanafil (Cas 330784-47-9) Production by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Production Market Share by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Production Value by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Sales Price by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Consumption by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Avanafil (Cas 330784-47-9) Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Avanafil (Cas 330784-47-9)
Figure Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
Figure Avanafil (Cas 330784-47-9) Industrial Chain Analysis
Table Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Major Buyers of Avanafil (Cas 330784-47-9)
Table DistributorsTraders List
Figure China Avanafil (Cas 330784-47-9) Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Table China Avanafil (Cas 330784-47-9) Production, Import, Export and Consumption Forecast (2016-2021)
Table China Avanafil (Cas 330784-47-9) Production Forecast by Type (2016-2021)
Table China Avanafil (Cas 330784-47-9) Consumption Forecast by Application (2016-2021)
Table China Avanafil (Cas 330784-47-9) Production Forecast by Regions (Provinces)(2016-2021)
Table China Avanafil (Cas 330784-47-9) Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Avanafil (Cas 330784-47-9) Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...